Nephron-sparing surgery for small-to-medium sized renal tumors has undoubtedly become a standard of patient management in the 21 st century. The recent trends toward nephron sparing stem from an ...

A study presented at the Society of Interventional Radiology’s 37th Annual Scientific Meeting in San Francisco, Calif. shows that percutaneous cryoablation may be provide another treatment alternative ...

"ProSense® received a high level of interest at this prestigious breast cancer conference in Europe where our cryoablation system is gaining increasing commercial traction driven by regulatory ...

March 11, 2009 (San Diego, California) — Interventional cryoablation is an effective treatment for small renal tumors, and should be the gold standard or first treatment option for all patients with ...

A minimally invasive procedure that destroys cancer cells by freezing them is as effective as surgery for treating early-stage kidney cancer, offering similar 10-year survival rates with a lower rate ...

Percutaneous radiofrequency ablation, although a promising therapy for small, solid renal tumors, is less suitable for large tumors or masses adjacent to critical structures, such as the bowel, and ...

Percutaneous cryoablation, a relatively non-invasive technique that destroys tumors by freezing them, is a safe method for treating kidney tumors in selected patients who are not considered candidates ...

Racial and gender disparities in renal cell carcinoma. The effects of HDIL-2 in combination with pazopanib or sunitinib on PBMCs’ function and RCC cells’ apoptosis: Preliminary in vitro data.

Introduction: The widespread use of ultrasound and cross-sectional imaging has led to a steady increase in the incidental discovery of renal masses. Most of them are treated with partial nephrectomy ...

CAESAREA, Israel, Oct. 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...

Feasibility study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II-IIIA non-small cell lung cancer. Background: Percutaneous cryoablation for lung tumors ...

Overall and disease-free survival was nearly 100% after a median follow-up of one year, study shows. SAN DIEGO—Percutaneous cryoablation for renal cell carcinoma is a safe modality that carries ...